Gross Margin

A shocking $31M loss forces ethical egg purveyor Vital Farms into a defensive crouch, testing if brand loyalty can survive a brutal market oversupply.

Bob's Discount Furniture's impressive Q2 earnings reveal a dual victory: a value proposition resonating with cautious consumers and a massive tariff refund.

Arhaus reported record profits, but a one-time tariff refund tells only half the story. We dig into the numbers to find the real drivers of future growth.

Estonian construction giant Nordecon posts a 37% revenue surge, but shrinking margins reveal the high cost of its pivot to public projects amidst market turmoil.

RECONOVA's massively oversubscribed IPO met a cool reception on its first day, signaling a new era where AI firms must prove profitability, not just potential.

Facing steep losses and a delisting threat, luxury furniture giant Natuzzi is shrinking its Italian footprint and betting on a new generation of leadership.

As Biofrontera preps its Q2 report, investors weigh record revenue and expanded margins against persistent losses and a critical need for cash flow breakeven.

Beyond record revenues, Park-Ohio's Q2 results reveal a strategic pivot, leveraging AI, aerospace, and electrification to forge a less cyclical, high-growth future.

With soaring revenues and a landmark Microsoft AI deal, A10 Networks is redefining its role. Is this the playbook for winning the AI infrastructure wars?

With a new $345 genome and major clinical wins, PacBio pushes boundaries. But can its strategic restructuring and bold R&D overcome mounting financial losses?

The clean-living brand's revenue is down, but profits and confidence are soaring. A deep dive into how strategic cuts are building a more durable company.

KORU Medical posts record profits, but the real story is its strategic overhaul. We dissect its oncology pivot and digital tech bet for long-term value.

The hormone optimization leader's stock tumbles after Q2 results show a net loss and declining revenue, revealing the prolonged impact of its January recall.

SmartRent’s surge to profitability and massive IoT booking growth signals a new era for rental housing, proving the digital backbone of our cities is here.

XPEL smashes Q2 estimates with record revenue, fueled by explosive China growth. But a costly manufacturing pivot tests its long-term strategy.

CDW's Q2 earnings beat expectations with a 10% sales jump, thanks to AI and cloud demand. But a dip in gross margins and restructuring costs spooked the market.

Pyxus International's Q1 sales fell, but a forensic look reveals a firm mastering a flooded market, boosting margins and shoring up its financial foundations.

NCR Atleos reports a 67% profit jump, driven by its service-led model. This financial strength fast-tracks its integration with Brink's, reshaping financial access.

LeMaitre reports double-digit growth driven by its Artegraft product, but misses analyst estimates. A deep dive into its global strategy and financial health.

Facing revenue headwinds from currency shifts and regulatory hurdles, China's Jin Medical doubles down on R&D and operational efficiency. A look inside their strategy.